摘要:
A method for treating core binding factor (CBF) leukemia in a subject, comprising administering to a subject having CBF leukemia a therapeutically effective amount of a compound, or a pharmaceutically acceptable salt or ester thereof, that inhibits CBFβ and RUNX1 binding in the subject, thereby treating the CBF leukemia.
摘要:
A method comprises creating a first node, determining whether an indicator associated with a head node is present, and designating the first node as a head node, defining and associating a head node identifier with the first node, define a link from the first node to the first node, and create and save an indicator associated with the head node responsive to determining that the indicator associated with a head node is not present.